IPSC (STOCKS)
Century Therapeutics, Inc. Common Stock
$2.400000
+0.150000 (+6.67%)
Prev close: $2.250000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Brent Pfeiffenberger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $409.73M
- Employees
- 165
- P/E (TTM)
- -21.56
- P/B (TTM)
- 1.25
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.22 | $-0.29 | +0.0690 | +23.88% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.34 | +0.0243 | +7.06% |
|
Jun 2025 (Q2)
|
$-0.38 | $-0.38 | +0.0035 | +0.91% |
|
Mar 2025 (Q1)
|
$0.89 | $0.06 | +0.8339 | +1,486.45% |
Financial Statements
| Revenues | $109.16M |
| Benefits Costs and Expenses | $118.81M |
| Costs And Expenses | $118.81M |
| Nonoperating Income/Loss | $7.62M |
| Operating Expenses | $126.43M |
| Operating Income/Loss | -$17.27M |
| Income/Loss From Continuing Operations After Tax | -$9.58M |
| Income/Loss From Continuing Operations Before Tax | -$9.65M |
| Income Tax Expense/Benefit | -$68.00K |
| Income Tax Expense/Benefit, Current | $5.00K |
| Income Tax Expense/Benefit, Deferred | -$73.00K |
| Net Income/Loss | -$9.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.14 |
| Diluted Earnings Per Share | -$0.14 |
| Basic Average Shares | 86,556,515 |
| Diluted Average Shares | 86,556,515 |
| Assets | $223.70M |
| Current Assets | $120.77M |
| Noncurrent Assets | $102.94M |
| Fixed Assets | $50.03M |
| Intangible Assets | $34.20M |
| Other Non-current Assets | $18.71M |
| Liabilities | $64.77M |
| Current Liabilities | $20.23M |
| Accounts Payable | $4.77M |
| Wages | $4.63M |
| Other Current Liabilities | $10.82M |
| Noncurrent Liabilities | $44.54M |
| Equity | $158.94M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $158.94M |
| Liabilities And Equity | $223.70M |
| Net Cash Flow From Operating Activities | -$103.88M |
| Net Cash Flow From Operating Activities, Continuing | -$103.88M |
| Net Cash Flow From Investing Activities | $107.50M |
| Net Cash Flow From Investing Activities, Continuing | $107.50M |
| Net Cash Flow From Financing Activities | $173.00K |
| Net Cash Flow From Financing Activities, Continuing | $173.00K |
| Net Cash Flow | $3.80M |
| Net Cash Flow, Continuing | $3.80M |
| Comprehensive Income/Loss | -$9.87M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.87M |
| Other Comprehensive Income/Loss | -$294.00K |